Privia Health Group, Inc. (NASDAQ:PRVA) Position Increased by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC lifted its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 185.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,999 shares of the company’s stock after acquiring an additional 3,249 shares during the period. Nisa Investment Advisors LLC’s holdings in Privia Health Group were worth $98,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Park Avenue Securities LLC raised its stake in Privia Health Group by 3.8% during the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after purchasing an additional 532 shares during the period. Sequoia Financial Advisors LLC raised its position in Privia Health Group by 2.3% during the third quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after buying an additional 583 shares during the period. GAMMA Investing LLC lifted its stake in Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after acquiring an additional 845 shares in the last quarter. KBC Group NV boosted its position in Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after acquiring an additional 871 shares during the period. Finally, Trust Point Inc. grew its stake in Privia Health Group by 3.5% during the 3rd quarter. Trust Point Inc. now owns 41,130 shares of the company’s stock valued at $749,000 after acquiring an additional 1,386 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on PRVA. Barclays raised their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Needham & Company LLC initiated coverage on shares of Privia Health Group in a report on Friday, January 10th. They set a “buy” rating and a $25.00 price target on the stock. Macquarie initiated coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. Truist Financial lifted their price objective on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Finally, JPMorgan Chase & Co. upped their target price on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Friday, November 29th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $24.88.

Privia Health Group Price Performance

Shares of PRVA opened at $22.54 on Friday. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $23.49. The company’s fifty day moving average price is $21.20 and its 200 day moving average price is $19.92. The company has a market capitalization of $2.70 billion, a PE ratio of 225.42, a price-to-earnings-growth ratio of 3.07 and a beta of 0.85.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.